levonorgestrel and ethinyl estradiol tablets usp 0.15 mg 0.03 mg

Levonorgestrel and ethinyl estradiol tablets usp 0.15 mg 0.03 mg

The photos shown are samples only Not all photos of the drug may be displayed.

Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive COC use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. Levonorgestrel and ethinyl estradiol tablets USP, 0. Each white to off-white active tablet contains the following inactive ingredients: lactose monohydrate, magnesium stearate, and polacrilin potassium. Combination oral contraceptives prevent pregnancy primarily by suppressing ovulation. Levonorgestrel and ethinyl estradiol tablets, 0. Levonorgestrel and ethinyl estradiol tablets are contraindicated in females who are known to have the following conditions:.

Levonorgestrel and ethinyl estradiol tablets usp 0.15 mg 0.03 mg

Levonorgestrel and ethinyl estradiol tablets USP are an extended-cycle oral contraceptive consisting of 84 pink active tablets each containing 0. The structural formulas are as follows:. Each white inert tablet contains the following inactive ingredients: croscarmellose sodium, lactose monohydrate, magnesium stearate and microcrystalline cellulose. Combination oral contraceptives act by suppression of gonadotropins. Although the primary mechanism of this action is inhibition of ovulation, other alterations include changes in the cervical mucus which increase the difficulty of sperm entry into the uterus and changes in the endometrium which reduce the likelihood of implantation. No specific investigation of the absolute bioavailability of levonorgestrel and ethinyl estradiol tablets in humans has been conducted. The effect of food on the rate and the extent of levonorgestrel and ethinyl estradiol absorption following oral administration of levonorgestrel and ethinyl estradiol tablets has not been evaluated. The apparent volume of distribution of levonorgestrel and ethinyl estradiol are reported to be approximately 1. Levonorgestrel is about Levonorgestrel and its phase I metabolites are excreted primarily as glucuronide conjugates. Metabolic clearance rates may differ among individuals by several-fold, and this may account in part for the wide variation observed in levonorgestrel concentrations among users. First-pass metabolism of ethinyl estradiol involves formation of ethinyl estradiolsulfate in the gut wall, followed by 2-hydroxylation of a portion of the remaining untransformed ethinyl estradiol by hepatic cytochrome P 3A4 CYP3A4. Levels of CYP3A4 vary widely among individuals and can explain the variation in rates of ethinyl estradiol hydroxylation. Hydroxylation at the 4-, 6-, and positions may also occur, although to a much lesser extent than 2-hydroxylation. The terminal elimination half-life for levonorgestrel after a single dose of levonorgestrel and ethinyl estradiol tablets about 30 hours.

Advertising and sponsorship policy Advertising and sponsorship opportunities. You should consider starting oral contraceptives only after you have weaned your child completely. Fluid Retention Oral contraceptives may cause some degree of fluid retention.

Levonorgestrel and ethinyl estradiol combination is used to prevent pregnancy. It works by stopping a woman's egg from fully developing each month. The egg can no longer accept a sperm and fertilization pregnancy is prevented. No contraceptive method is percent effective. Birth control methods such as having surgery to become sterile or not having sex are more effective than birth control pills.

Levonorgestrel and ethinyl estradiol tablets USP are an extended-cycle oral contraceptive consisting of 84 pink active tablets each containing 0. The structural formulas are as follows:. Each white inert tablet contains the following inactive ingredients: croscarmellose sodium, lactose monohydrate, magnesium stearate and microcrystalline cellulose. Combination oral contraceptives act by suppression of gonadotropins. Although the primary mechanism of this action is inhibition of ovulation, other alterations include changes in the cervical mucus which increase the difficulty of sperm entry into the uterus and changes in the endometrium which reduce the likelihood of implantation. No specific investigation of the absolute bioavailability of levonorgestrel and ethinyl estradiol tablets in humans has been conducted. The effect of food on the rate and the extent of levonorgestrel and ethinyl estradiol absorption following oral administration of levonorgestrel and ethinyl estradiol tablets has not been evaluated. The apparent volume of distribution of levonorgestrel and ethinyl estradiol are reported to be approximately 1. Levonorgestrel is about

Levonorgestrel and ethinyl estradiol tablets usp 0.15 mg 0.03 mg

It is very important that you use this medicine exactly as directed by your doctor. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered. This medicine comes with patient instructions. Read and follow these instructions carefully. Ask your doctor or pharmacist if you have any questions. When you begin using this medicine, your body will require at least 7 days to adjust before a pregnancy will be prevented. Use a second form of birth control, such as a condom, spermicide, or diaphragm, for the first 7 days of your first cycle of pills.

Roselia evolution level

Legal Conditions and Terms Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below. Levonorgestrel and ethinyl estradiol tablets may decrease the amount of breast milk you make. Other side effects Other side effects may include nausea and vomiting, change in appetite, breast tenderness, headache, nervousness, depression, dizziness, loss of scalp hair, rash, vaginal infections, and allergic reactions. The risk of postpartum thromboembolism decreases after the third postpartum week, whereas the likelihood of ovulation increases after the third postpartum week. Carcinoma of the Reproductive Organs and Breasts Numerous epidemiological studies have been performed on the incidence of breast, endometrial, ovarian and cervical cancer in women using oral contraceptives. The inert tablets are white to off white tablets with "LU" on one side and "U22" on the other side. The attributable risk is also greater in older women. Part 2 of 2. If the patient has not adhered to the prescribed dosing schedule missed one or two active tablets or started taking them on a day later than she should have , consider the possibility of pregnancy at the time of the first missed period and perform appropriate diagnostic measures. However, this may be due to other reasons such as having more sexual partners. Women with a history of hypertension or hypertension-related diseases, or renal disease should be encouraged to use another method of contraception. Know the medicines you take.

.

You may choose to take this medication at another time of day that is easier for you to remember. Women with any of these conditions should be checked often by their healthcare provider if they choose to use oral contraceptives. The risk does not increase with duration of use and no consistent relationships have been found with dose or type of steroid. The patient should be advised to use a nonhormonal back-up method for the first 7 days of tablet-taking. Do not change your schedule on your own. If vomiting occurs within 3 to 4 hours after taking levonorgestrel and ethinyl estradiol tablets, the patient should proceed as if she missed a tablet. Practitioners prescribing oral contraceptives should be familiar with the following information relating to these risks. Additional nonhormonal contraception such as condoms or spermicide should be used as back-up if the patient has sex within 7 days after missing tablets. Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. Among nonusers in the same age group, about 1 in 20, would be hospitalized each year. Do not use the drug for any condition other than the one for which it was prescribed. Day 1 start: Throw out the rest of the pack and start a new pack that same day.

2 thoughts on “Levonorgestrel and ethinyl estradiol tablets usp 0.15 mg 0.03 mg

  1. It is very a pity to me, I can help nothing, but it is assured, that to you will help to find the correct decision.

Leave a Reply

Your email address will not be published. Required fields are marked *